MARKET

SRDX

SRDX

Surmodics Inc
NASDAQ
34.71
-1.31
-3.64%
After Hours: 34.71 0 0.00% 16:02 11/28 EST
OPEN
35.61
PREV CLOSE
36.02
HIGH
36.10
LOW
34.42
VOLUME
24.20K
TURNOVER
0
52 WEEK HIGH
50.86
52 WEEK LOW
28.28
MARKET CAP
487.33M
P/E (TTM)
-17.7273
1D
5D
1M
3M
1Y
5Y
Surmodics Announces 12-Month Data From SWING Trial Presented At VEITHsymposium
Benzinga · 11/17 13:33
BRIEF-Surmodics Announces Swing Trial 12-Month Data To Be Presented At Veithsymposium On Nov. 16
Reuters · 11/11 14:34
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
EDEN PRAIRIE, Minn., November 11, 2022--Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
Business Wire · 11/11 13:30
Surmodics Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
Surmodics ( NASDAQ:SRDX ) Full Year 2022 Results Key Financial Results Revenue: US$100.0m (down 4.9% from FY 2021). Net...
Simply Wall St. · 11/11 10:53
Surmodics (SRDX) Q4 Earnings and Revenues Top Estimates
Surmodics (SRDX) reports a solid fiscal fourth quarter top line on the back of robust Medical Device revenues.
Zacks · 11/10 13:35
Surmodics Non-GAAP EPS of -$0.26 beats by $0.19, revenue of $26M beats by $1.91M
Seekingalpha · 11/09 12:48
Surmodics Non-GAAP EPS of -$0.26 beats by $0.19, revenue of $25.99M beats by $1.9M
Seekingalpha · 11/09 12:46
Surmodics Sees FY23 Adj EPS Of $(2.54)-$(2.14) vs. Consensus of $(1.23)
Benzinga · 11/09 12:24
More
About SRDX
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment manufactures performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilizers, substrates, surface coatings and antigens.

Webull offers kinds of SurModics, Inc. stock information, including NASDAQ:SRDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRDX stock methods without spending real money on the virtual paper trading platform.